Name:
"Moraxella lacunata subsp. lacunata" (Eyre 1900) Lwoff 1939
DSM No.:
18052, Type strain dsm-18052 dsm18052 dsm 18052 Moraxella lacunata subsp. lacunata
Strain designation:
CIP A182, ATCC 17967, CCUG 4441, NCTC 11011, Morax 260
Other collection no.
or WDCM no.:
CIP A182,ATCC 17967,CCUG 4441,NCTC 11011
Isolated from:
human conjunctivitis
Date of sampling:
before 13.03.2006
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- CIP <- R. Legronx, Inst. Pasteur Paris; Morax 260
Summary and
additional information:
<- CIP <- R. Legronx, Inst. Pasteur Paris; Morax 260. Human conjunctivitis; France. Type strain. Taxonomy/description (1300, 5518, 10325, 10326). Sequence accession no. AF005160. (Medium 693, 30°C).
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 120,- € |
| Active culture on request | | 280,- € |
| DNA | | 180,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
